Vioxx Importation On The Horizon? Health Canada Open To Rofecoxib Return
Executive Summary
Health Canada appears open to the reintroduction of Merck's COX-2 inhibitor Vioxx, Health Canada Manager of Marketed Pharmaceuticals Marc Berthiaume indicated during a July 7 media call